Prasol Chemicals IPO Oversubscribed 3.3 Times on Strong Investor Demand

Prasol Chemicals IPO Sees Robust Demand, Oversubscribed 3.3 Times

Strong interest from institutional and retail investors highlights confidence in Prasol Chemicals’ growth potential.

Investor Participation Breakdown

The IPO’s success was driven by robust participation from qualified institutional buyers (QIBs), who subscribed 7.22 times their allocated portion. Non-institutional investors (NIIs) showed a healthy subscription rate of 1.80 times, while retail individual investors (RIIs) contributed with a subscription rate of 1.70 times. This diverse interest underscores the market’s confidence in Prasol Chemicals’ business model and growth trajectory.

IPO Structure and Financial Objectives

The IPO consists of a fresh issue of equity shares worth up to Rs 500 crore, alongside an offer for sale totaling Rs 80 crore from existing shareholders. The fresh issue aims to raise funds for specific purposes, including Rs 60 crore allocated for the repayment or pre-payment of certain outstanding borrowings, with the remainder earmarked for general corporate purposes. This strategic allocation of funds is expected to strengthen the company’s balance sheet and support its future growth initiatives.

Company Overview and Market Position

Founded in 1992, Prasol Chemicals is a forward-integrated manufacturer specializing in acetone- and phosphorus-based specialty chemicals. With over 33 years of industry experience, the company boasts a diverse portfolio of more than 150 products, serving over 1,600 customers across 69 countries. Its manufacturing facilities in Khopoli and Mahad, Maharashtra, have a combined installed capacity of 98,644 tonnes per annum. The company’s product offerings cater to various sectors, including performance chemicals, paints, inks, pharmaceuticals, agrochemicals, and personal care.

Financial Performance and Growth Prospects

In the fiscal year ending March 31, 2026, Prasol Chemicals reported a consolidated net profit of Rs 83.12 crore on sales of Rs 1,232.59 crore. The revenue breakdown indicates that acetone-based specialty chemicals contributed 42.75%, phosphorus-based specialty chemicals accounted for 38.30%, and other specialty chemicals made up 18.33%. This diversified revenue stream positions the company favorably for future growth, especially as demand for specialty chemicals continues to rise globally.

Key Highlights

• Prasol Chemicals IPO oversubscribed 3.30 times, reflecting strong investor interest.
• QIB portion subscribed 7.22 times, indicating confidence from institutional investors.
• Fresh issue of equity shares aims to raise Rs 500 crore for debt repayment and corporate purposes.
• Company reported a consolidated net profit of Rs 83.12 crore for FY26.
• Diverse product portfolio serves multiple sectors, enhancing growth potential.

Investor Note: The strong subscription rates across all investor categories suggest a positive outlook for Prasol Chemicals, making it an attractive investment opportunity for those looking to capitalize on the growing specialty chemicals market.